http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2087534-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_670101b0e1b717a61558c95d26de20eb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
filingDate 1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef3334e969be4bd729fc4544ce1db5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_047b9a585775bc0ef0e9be8ef71465db
publicationDate 1992-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2087534-A1
titleOfInvention Di(2-propyl)esters of 1-fluoro-2-phosphonomethoxy-3-p-toluenesulfonyloxypropanes, their production and utilization
abstract The invention relates to new compounds, di(2-propyl)esters of (R)-, (S)- and (RS)-1-fluoro-2-phosphonomethoxy-3-p-tolu-enesulfonyloxypropane and the method of producing them. The compounds can be used with advantage in the preparation of N-(3-fluoro-2-phosphonomethoxypropyl) derivatives of heterocyclic purine and pyrimidine bases that have antiviral activity.
priorityDate 1991-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420227563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18963232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410062813

Total number of triples: 20.